Tu Li, Xie Hong, Li Qi, Lei Ping-Gui, Zhao Pei-Ling, Yang Fan, Gong Chi, Yao Yuan-Lin, Zhou Shi
Department of General Practice, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou Province, China.
Clinical Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China.
World J Hepatol. 2024 May 27;16(5):800-808. doi: 10.4254/wjh.v16.i5.800.
In recent years, approximately half of the newly diagnosed cases and mortalities attributed to hepatocellular carcinoma (HCC) have been reported in China. Despite the high incidence of HCC, there remains a paucity of data regarding the natural growth pattern and the determination of optimal surveillance intervals specific to the Chinese population.
To quantify the natural tumor growth pattern of HCC in regional China.
A retrospective analysis was performed on patients from a single institution in Southwest China who had undergone two or more serial dynamic computed tomography or magnetic resonance imaging scans between 2014 and 2020, without having received any anti-cancer therapy. Tumor growth was assessed using tumor volume doubling time (TVDT) and tumor growth rate (TGR), with volumes measured manually by experienced radiologists. Simple univariate linear regression and descriptive analysis were applied to explore associations between growth rates and clinical factors.
This study identifies the median TVDT for HCC as 163.4 d, interquartile range (IQR) 72.1 to 302.3 d, with a daily TGR of 0.42% (IQR 0.206%-0.97%). HCC growth patterns reveal that about one-third of tumors grow indolently with TVDT exceeding 270 d, another one-third of tumors exhibit rapid growth with TVDT under 90 d, and the remaining tumors show intermediate growth rates, with TVDT ranging between 3 to 9 months.
The identified TGRs support biannual surveillance and follow-up for HCC patients in certain regions of China. Given the observed heterogeneity in HCC growth, further investigation is warranted.
近年来,中国报告的肝细胞癌(HCC)新诊断病例和死亡病例约占全球的一半。尽管HCC发病率很高,但关于其自然生长模式以及针对中国人群的最佳监测间隔的确定,数据仍然匮乏。
量化中国特定地区HCC的自然肿瘤生长模式。
对中国西南部一家单一机构的患者进行回顾性分析,这些患者在2014年至2020年间接受了两次或更多次连续动态计算机断层扫描或磁共振成像扫描,且未接受任何抗癌治疗。使用肿瘤体积倍增时间(TVDT)和肿瘤生长率(TGR)评估肿瘤生长,由经验丰富的放射科医生手动测量体积。应用简单单变量线性回归和描述性分析来探索生长率与临床因素之间的关联。
本研究确定HCC的中位TVDT为163.4天,四分位间距(IQR)为72.1至302.3天,每日TGR为0.42%(IQR 0.206%-0.97%)。HCC生长模式显示,约三分之一的肿瘤生长缓慢,TVDT超过270天;另有三分之一的肿瘤生长迅速,TVDT低于90天;其余肿瘤显示中等生长率,TVDT在3至9个月之间。
所确定的TGR支持对中国某些地区的HCC患者进行半年一次的监测和随访。鉴于观察到的HCC生长异质性,有必要进一步研究。